Investment Analysts’ Updated EPS Estimates for August 17th (ADI, ALLO, ALP, AMCR, ANP, ARE, AZUL, BVS, CCAP, CELC)

Investment Analysts’ updated eps estimates for Monday, August 17th:

Analog Devices (NASDAQ:ADI) had its overweight rating reissued by analysts at Cantor Fitzgerald. They currently have a $550.00 price target on the stock.

Allogene Therapeutics (NASDAQ:ALLO) had its market outperform rating reiterated by analysts at Citizens Jmp. Citizens Jmp currently has a $6.00 target price on the stock.

HC Wainwright began coverage on shares of Portage Biotech (NASDAQ:ALP). HC Wainwright issued a neutral rating and a $0.25 target price on the stock.

Amcor (NYSE:AMCR) had its neutral rating reissued by analysts at JPMorgan Chase & Co.. They currently have a $47.00 target price on the stock, up from their previous target price of $44.00.

Anpario (LON:ANP) had its house stock rating reiterated by analysts at Shore Capital Group Ltd.

Alexandria Real Estate Equities (NYSE:ARE) had its market perform rating reiterated by analysts at Citizens Jmp.

Azul (NYSE:AZUL) had its buy rating reiterated by analysts at BWS Financial. The firm currently has a $20.00 price target on the stock.

Bioventus (NASDAQ:BVS) had its overweight rating reissued by analysts at Cantor Fitzgerald. The firm currently has a $15.00 price target on the stock.

Crescent Capital BDC (NASDAQ:CCAP) had its market perform rating reissued by analysts at Keefe, Bruyette & Woods. They currently have a $12.00 target price on the stock, down from their previous target price of $13.00.

Celcuity (NASDAQ:CELC) had its market outperform rating reissued by analysts at Citizens Jmp. They currently have a $177.00 target price on the stock.

Capstone Energy+ (NASDAQ:CEPL) had its buy rating reaffirmed by analysts at BWS Financial. They currently have a $20.00 price target on the stock.

Cullinan Therapeutics (NASDAQ:CGEM) had its buy rating reiterated by analysts at HC Wainwright. They currently have a $30.00 target price on the stock.

Americold Realty Trust (NYSE:COLD) had its sector perform rating reiterated by analysts at Royal Bank Of Canada. Royal Bank Of Canada currently has a $16.00 target price on the stock.

Curis (NASDAQ:CRIS) had its buy rating reissued by analysts at HC Wainwright.

Domo (NASDAQ:DOMO) had its market underperform rating reissued by analysts at Citizens Jmp. Citizens Jmp currently has a $2.25 target price on the stock.

Bright Minds Biosciences (NASDAQ:DRUG) had its buy rating reiterated by analysts at BTIG Research. The firm currently has a $147.00 target price on the stock.

Devon Energy (NYSE:DVN) had its buy rating reissued by analysts at Argus. Argus currently has a $45.85 price target on the stock.

Estee Lauder Companies (NYSE:EL) had its outperform rating reissued by analysts at Royal Bank Of Canada. Royal Bank Of Canada currently has a $111.00 price target on the stock.

Eyepoint Pharmaceuticals (NASDAQ:EYPT) had its neutral rating reaffirmed by analysts at JPMorgan Chase & Co..

Eyepoint Pharmaceuticals (NASDAQ:EYPT) had its buy rating reissued by analysts at Chardan Capital. They currently have a $65.00 price target on the stock.

HIVE Digital Technologies (NASDAQ:HIVE) had its buy rating reiterated by analysts at HC Wainwright. The firm currently has a $7.00 price target on the stock.

Jefferies Financial Group Inc. began coverage on shares of Honeywell International (NASDAQ:HON). Jefferies Financial Group Inc. issued a hold rating and a $255.00 target price on the stock.

Craig Hallum began coverage on shares of Horizon Quantum Computing Pte. (NASDAQ:HQ). They issued a buy rating and a $21.00 target price on the stock.

Wedbush initiated coverage on shares of Immunic (NASDAQ:IMUX). They issued an outperform rating and a $45.00 price target on the stock.

Interparfums (NASDAQ:IPAR) had its neutral rating reissued by analysts at BWS Financial. BWS Financial currently has a $85.00 price target on the stock.

Kodiak Sciences (NASDAQ:KOD) had its buy rating reaffirmed by analysts at HC Wainwright. They currently have a $58.00 target price on the stock.

Lucid Diagnostics (NASDAQ:LUCD) had its buy rating reaffirmed by analysts at BTIG Research. BTIG Research currently has a $2.50 price target on the stock.

Microchip Technology (NASDAQ:MCHP) had its overweight rating reiterated by analysts at Cantor Fitzgerald. The firm currently has a $125.00 price target on the stock.

MDA Space (NYSE:MDA) had its outperform rating reiterated by analysts at Royal Bank Of Canada. Royal Bank Of Canada currently has a $60.00 price target on the stock.

MiMedx Group (NASDAQ:MDXG) had its overweight rating reaffirmed by analysts at Cantor Fitzgerald. They currently have a $8.00 price target on the stock.

Satellos Bioscience (NASDAQ:MSLE) had its buy rating reissued by analysts at HC Wainwright. The firm currently has a $18.00 target price on the stock.

M.T.I Wireless Edge (LON:MWE) had its house stock rating reiterated by analysts at Shore Capital Group Ltd.

Nano-X Imaging (NASDAQ:NNOX) had its overweight rating reissued by analysts at Cantor Fitzgerald. The firm currently has a $5.00 target price on the stock.

ServiceNow (NYSE:NOW) had its buy rating reiterated by analysts at TD Cowen. They currently have a $140.00 target price on the stock.

Netskope (NASDAQ:NTSK) had its buy rating reiterated by analysts at TD Cowen. They currently have a $19.00 target price on the stock.

NXP Semiconductors (NASDAQ:NXPI) had its overweight rating reissued by analysts at Cantor Fitzgerald. The firm currently has a $400.00 price target on the stock.

OmniAb (NASDAQ:OABI) had its buy rating reaffirmed by analysts at HC Wainwright. The firm currently has a $11.00 target price on the stock.

Chardan Capital assumed coverage on shares of Odysight.ai (NASDAQ:ODYS). Chardan Capital issued a buy rating and a $7.15 target price on the stock.

onsemi (NASDAQ:ON) had its neutral rating reaffirmed by analysts at Cantor Fitzgerald. Cantor Fitzgerald currently has a $110.00 price target on the stock.

Blue Owl Technology Finance (NYSE:OTF) had its sector perform rating reiterated by analysts at Royal Bank Of Canada. They currently have a $12.00 target price on the stock.

Truist Financial Corporation started coverage on shares of Pacira BioSciences (NASDAQ:PCRX). The firm issued a buy rating and a $30.00 price target on the stock.

Needham & Company LLC assumed coverage on shares of Pulse Biosciences (NASDAQ:PLSE). They issued a buy rating and a $58.00 price target on the stock.

Sunrun (NASDAQ:RUN) had its sell rating reissued by analysts at Glj Research. They currently have a $4.63 price target on the stock.

Soluna (NASDAQ:SLNH) had its buy rating reissued by analysts at HC Wainwright. The firm currently has a $4.00 target price on the stock.

SSP Group (LON:SSPG) had its buy rating reaffirmed by analysts at Deutsche Bank Aktiengesellschaft. The firm currently has a GBX 262 price target on the stock.

Texas Instruments (NASDAQ:TXN) had its neutral rating reaffirmed by analysts at Cantor Fitzgerald. They currently have a $340.00 target price on the stock.

Citigroup Inc. initiated coverage on shares of Universal Music Group (OTCMKTS:UMGNF). The firm issued a buy rating on the stock.

Vera Therapeutics (NASDAQ:VERA) had its neutral rating reaffirmed by analysts at Wedbush. Wedbush currently has a $34.00 price target on the stock.

Watsco (NYSE:WSO) had its overweight rating reissued by analysts at Stephens. Stephens currently has a $485.00 price target on the stock.

cbdMD (NYSEAMERICAN:YCBD) had its hold rating reissued by analysts at Maxim Group.

York Space Systems (NYSE:YSS) had its neutral rating reissued by analysts at JPMorgan Chase & Co.. They currently have a $17.00 target price on the stock, down from their previous target price of $38.00.